Shiga toxins do not directly stimulate alpha-granule secretion or enhance aggregation of human platelets

Acta Haematologica

Volumn 102, Issue 1, 1999, Pages 51-55

  Thorpe, C M ^a   Flaumenhaft, R ^b   Hurley, B ^a   Jacewicz, M ^a   Acheson, D W K ^a   Keusch, Gerald T ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PADGEM PROTEIN; SHIGA TOXIN;

ARTICLE; CONTROLLED STUDY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; BACTERIAL TOXINS; CYTOPLASMIC GRANULES; CYTOTOXINS; ESCHERICHIA COLI; FEMALE; HUMANS; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; SHIGA TOXINS;

EID: 0032820504     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040968     Document Type: Article

References (17)

1. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H: The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985;151:775-782.
2. Whitington PF, Friedman AL, Chesney RW: Gastrointestinal disease in the hemolytic uremic syndrome. Gastroenterology 1979;76:728-733.
3. Lieberman E, Heuser E, Donnell GN, Landing BH, Hammond GD: Hemolytic uremic syndrome. Clinical and pathological considerations. N Engl J Med 1966;275:227-236.
4. Appiani AC, Edefonti A, Bettinelli A, Cossu MM, Paracchini ML, Rossi E: The relationship between plasma levels of the factor VIII complex and platelet release products (β-thromboglobulin and platelet factor 4) in children with the hemolytic uremic syndrome. Clin Nephrol 1982;17:195-199.
5. Katayama M, Handa M, Araki Y, Ambo H, Kawai Y, Watanabe K, Ideda Y: Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol 1993; 84:702-710.
6. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN: Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994;83:1535-1541.
7. Benigni A, Boccardo P, Noris M, Remuzzi G, Siegler RL: Urinary excretion of platelet activating factor in hemolytic uremic syndrome. Lancet 1992;339:835-836.
8. Fong JSC, Kaplan BS: Impairment of platelet aggregation in hemolytic uremic syndrome: Evidence for platelet 'exhaustion'. Blood 1982; 60:564-570.
9. Walters MDS, Levin M, Smith C, Nokes TJC, Hardisty RM, Dillon MJ, Barrait TM: Intravascular platelet activation in the hemolytic uremic syndrome. Kidney Int 1988;33:107-115.
10. Rose PE, Armour JA, Williams CE, Hill FGH: Verotoxin and neuraminidase-induced platelet aggregating activity in plasma: Their possible role in the pathogenesis of the hemolytic uremic syndrome. J Clin Pathol 1985;38:438-441.
11. Jacewicz M, Acheson DWK, King A, Erban J, Keusch GT: Pathogenesis of Shiga-like toxin induced thrombotic microangiopathies: Effects of toxin on platelets (abstract). IDSA 33rd Annual Meeting. Infectious Diseases Society of America. San Francisco 1995.
12. Tao RVP, Sweeley CC, Jamieson GA: Sphingolipid composition of human platelets. J Lipid Res 1973;14:16-23.
13. Donahue-Rolfe A, Acheson DW, Kane AV, Keusch GT: Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies. Infect Immun 1989; 57:3888-3893.
14. Hsu Lin S, Berman CL, Furie BC, August D, Furie B: A platelet membrane protein expressed during platelet activation and secretion studies using a monoclonal antibody specific for thrombin activated platelets. J Biol Chem 1984;259:9121-9126.
15. McEver RP, Martin MN: A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984;259: 9799-9804.
16. Acheson DWK, DeBreucker SA, Jacewicz M, Lincicome LL, Donahue-Rolfe A, Kane AV, Keusch GT: Expression and purification of Shiga-like toxin II B subunits. Infect Immun 1995;63:301-308.
17. Yoshimura K, Fujii J, Yutsudo T, Kikuchi R, Soejima T, Shirahata S, Yoshida S: No direct effects of Shiga toxin 1 and 2 on the aggregation of human platelets in vitro. Thromb Haemost 1998;80:529-530.